Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07382674 · ClinicalTrials.gov registry record · NA
Zesty Exercise System for Therapeutic Engagement
A NA study, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT07382674: Recruiting NA study, sponsored by Emory University.
NCT07382674 is a NA study that is actively recruiting participants, run by Emory University. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07382674, a NA study, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study will evaluate exercise delivered through the Zesty Exercise System for Therapeutic Engagement (ZEST-E) for people with Parkinson's disease when sessions are monitored either in person or remotely. Participants will complete robot-guided exercise three times per week for three weeks. The study will assess feasibility, retention, safety, acceptability, and tolerability of remotely monitored ZEST-E and will measure changes in functional performance using the Standing Forward Reach test and the 30-Second Chair Stand test. These outcomes reflect range of motion and lower-body strength targeted by the exercise program.
Primary Outcome
This test measures forward reach distance while standing to assess range of motion and postural control. Greater reach distance indicates improved mobility.
Interventions
- DEVICE ZEST-E Robot-Assisted Exercise Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2026-03-16 |
| Est. Completion | 2028-02 |
| Phase | NA |
What NCT07382674 shows while recruiting
NCT07382674 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which ZEST-E Robot-Assisted Exercise Program is the first listed.
NCT07382674 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07382674 about?
NCT07382674 is a clinical study titled "Zesty Exercise System for Therapeutic Engagement". This study will evaluate exercise delivered through the Zesty Exercise System for Therapeutic Engagement (ZEST-E) for people with Parkinson's disease when sessions are monitored either in person or remotely. Participants will complete robot-guided exercise three times per week for three weeks. The s...
What is the current status of trial NCT07382674?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2026-03-16. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07382674?
The interventions under investigation include: ZEST-E Robot-Assisted Exercise Program (DEVICE).
Who is sponsoring clinical trial NCT07382674?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07382674's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI